Support Tools for Families of Potential Deceased Organ Donors Remain Uneven and Understudied
Families confronted with a potential deceased organ donor face one of the most difficult moments in acute care. The scoping review in BMJ Open set out to identify support tools designed to assist those families, a question with direct relevance to bedside communication, consent discussions, and end-of-life care. Deceased donation itself is uncommon, and it occurs through two pathways: donation after death determination by circulatory criteria and donation after death determination by neurologic criteria, also known as brain death. Each pathway carries different clinical timelines, family expectations, and emotional burdens, yet both place relatives in the center of urgent decision-making.
A scoping review is the right design for a field like this because the literature is likely to be dispersed across clinical practice, ethics, communication research, and donor care systems. The review followed Joanna Briggs Institute methodology and used the PRISMA-ScR checklist, which gives the work a structured and transparent framework. English-language publications were the only studies considered, and grey literature and unpublished studies were left out. Those choices shape what can be claimed from the evidence base, but they also make the review more manageable and methodologically clear.
The need for support tools is not abstract. When families are asked to process a death, understand the medical circumstances, and weigh donation, they may be doing so within hours of a devastating change in condition. Clinicians often must explain death determination, clarify whether donation is possible, and communicate in a setting where shock, uncertainty, and grief are already present. A support tool in this context may be informational, educational, communicative, or decision-oriented, but the central question is whether families receive enough structure to navigate the conversation with less distress and more comprehension.
Why Donation Conversations Need Structured Family Support
At the bedside, the donation conversation depends on more than technical accuracy. Families need plain language, emotional support, and enough time to absorb what death determination means before any discussion of donation can be meaningful. The distinction between circulatory criteria and neurologic criteria matters because each pathway changes the trajectory of care in different ways, and relatives may interpret those differences through the lens of confusion or mistrust if explanation is poor.
A support tool can serve several clinical purposes at once. It may improve family understanding of death determination, reduce miscommunication, standardize explanations across clinicians, or create a more humane pathway through a highly charged discussion. In practice, tools like these can also support transplant teams and intensive care clinicians by reducing the burden on individual staff members to improvise every conversation from scratch. Even so, a tool is only useful if it aligns with how families actually experience critical illness, dying, and bereavement.
The review’s focus on support tools for families of potential donors points to an important gap in the donation process itself. Donation systems are often built around organ recovery logistics, eligibility criteria, and coordination between services. Family-facing supports may receive less systematic attention, even though relatives are the people who must interpret the medical facts and often decide whether donation proceeds. In that sense, the review examines a part of the donation pathway that can determine whether the process is experienced as compassionate and comprehensible or rushed and opaque.
One sentence stands out in clinical terms: family support cannot be an afterthought when donation discussions are unfolding alongside death determination.
What the Review Adds to Practice and Policy
The review was designed to identify support tools rather than measure a treatment effect, so its value lies in mapping what exists and where the gaps remain. That type of evidence is especially useful for transplant programs, intensive care units, and policy makers trying to design family-centered donation pathways. A scoping review can reveal whether tools are concentrated in one type of donation pathway, whether they are aimed at information delivery or emotional support, and whether they have been developed with families in mind or primarily for staff use.
The methodological safeguards matter here. Following Joanna Briggs Institute guidance and PRISMA-ScR supports a transparent search and synthesis process. Yet the restrictions also narrow the field: limiting the review to English-language publications can omit relevant work from other health systems, and excluding grey literature can leave out protocols, hospital materials, and quality improvement initiatives that never reached formal publication. Those omissions do not invalidate the review, but they do define its boundaries.
For clinicians, the most practical implication is straightforward. Communication around donation should not rely solely on individual improvisation during a crisis. Families benefit when information is organized, repeated when needed, and delivered in a way that reflects the realities of shock, grief, and cognitive overload. If the literature is sparse or fragmented, that is itself a finding with bedside importance: the support structures surrounding donor families may not be as developed as the clinical process demands.
Evidence Gaps Still Limit Family-Facing Donation Care
Because the abstract available here does not provide the specific tools identified or the number of studies included, the review cannot be stretched beyond its documented scope. Even so, the clinical message is clear enough. Deceased organ donation depends on a conversation with families at a moment when medical urgency and bereavement collide, and the quality of that conversation may influence whether donation is understood as a respectful option or an added burden.
The most useful next steps are likely to come from more detailed evaluation of the tools themselves: how they are delivered, whether families find them understandable, and whether they improve communication without adding pressure. Tools aimed at potential donors’ relatives also need to be tested across different donation pathways, because circulatory and neurologic determination of death are not experienced in the same way by families or clinicians.
Until that evidence is stronger, the safest conclusion is operational rather than aspirational. Donation programs need family support approaches that are explicit, structured, and grounded in the realities of end-of-life communication, not merely in transplant logistics. The remaining question is not whether support matters, but which tools work best, for which families, and in which donation pathway.